Skip to content

Read-only version: For security reasons, the Research Information System (FIS) has been temporarily replaced by this read-only version. All public content and full texts remain available; login, editing, submission and statistics are not available. Questions: fis@uni-bamberg.de

Home › Publications › Implications for R&D and knowledge transfer in pharmaceutical companies after the acquisition of a biotech company

Publication

Implications for R&D and knowledge transfer in pharmaceutical companies after the acquisition of a biotech company

Schweizer, Lars (2004): Implications for R&D and knowledge transfer in pharmaceutical companies after the acquisition of a biotech company, in: Sten Jönsson, R. Wolff, Sten Jönsson, u. a. (Hrsg.), SAM/IFSAM VII World Congress: Management in a World of Diversity and Change. 5 - 7 Juli 2004, Göteborg, Schweden, Göteborg.

Details

Faculty/Chair
Author
Schweizer, Lars
Title of the compilation
SAM/IFSAM VII World Congress: Management in a World of Diversity and Change. 5 - 7 Juli 2004, Göteborg, Schweden
Editors
Jönsson, Sten
Wolff, R.
Conference
SAM/IFSAM VII World Congress: Management in a World of Diversity and Change. 5 - 7 Juli 2004, Göteborg, Schweden
Year of publication
2004
Language
English
Type
Conferenceobject
URI
Activation date
2014-09-24, 2014-09-24

Permalink: https://fis.uni-bamberg.de/handle/uniba/12991 · Data as JSON · Cite: BibTeX · RIS

Data as of: 2026-11-16

Restricted read-only access: login, editing and submission are temporarily disabled.